Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 16/11/2018
SIETES contiene 92578 citas

 
 
 1 a 10 de 10 
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Bohula EA, Wiviott SD, McGuire DK, Inzucchi SE, Kuder J, Im K, Fanola CL, Qamar A, Brown C, Budaj A, García-Castillo A, Gupta M, Leiter LA, Weissman NJ, White HD, Patel T, Francis B, Miao W, Perdomo C, Dhadda S, Bonaca MP, Ruff CT, Keech AC, Smith SR, Sabatine MS, Scirica BM, CAMELLIA–TIMI 61 Steering Committee and Investigators. Cardiovascular safety of lorcaserin in overweight or obese patients. N Engl J Med 2018:26 de agosto. [Ref.ID 102827]
2.Enlace a cita original Cita con resumen
Abdullah SM, Defina LF, Leonard D, Barlow CE, Radford NB, Willis BJ, Rohatgi A, McGuire DK, de Lemos JA, Grundy SM, Berry JD, Khera A. Long-term association of low-density lipoprotein cholesterol with cardiovascular mortality in individuals at low 10-year risk of atherosclerotic cardiovascular disease results from the Cooper Center Longitudinal Study. Circulation 2018;138:16 de agosto. [Ref.ID 102796]
3. Cita con resumen
Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR, for the TECOS Study Group. Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes. N Engl J Med 2015;373:232-42. [Ref.ID 99350]
4. Cita con resumen
Inzucchi SE, Lipska KJ, Mayo H, Bailey CJ, McGuire DK. Metformin in patients with type 2 diabetes and kidney disease: a systematic review. JAMA 2014;312:2668-75. [Ref.ID 98436]
5.Tiene citas relacionadas Cita con resumen
Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med 2013;369:1317-26. [Ref.ID 96330]
6.Tiene citas relacionadas Cita con resumen
Drazner M, McGuire DK, de Lemos JA. Nesiritide in acute heart failure. Lancet 2003;362:999. [Ref.ID 67462]
7.Tiene citas relacionadas Cita con resumen
Drazner M, McGuire DK, de Lemos JA. Nesiritide in acute heart failure. Authors' reply. Lancet 2003;362:998-9. [Ref.ID 67461]
8. Cita con resumen
de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet 2003;362:316-22. [Ref.ID 66967]
9.Tiene citas relacionadas
de Lemos JA, McGuire DK. Aspirin, clopidogrel, or both for secondary prevention of coronary disease. N Engl J Med 2003;348:561. [Ref.ID 65039]
10.Tiene citas relacionadas Cita con resumen
Newby L K, Kristinsson A, Bhapkar MV, Aylward PE, Dimas AP, Klein WW, McGuire DK, Moliterno DJ, Verheugt FWA, Weaver WD, Califf RM, for the SYMPHONY and 2nd SYMPHONY Investigators. Early statin initiation and outcomes in patients with acute coronary syndromes. JAMA 2002;287:3087-95. [Ref.ID 62536]
Seleccionar todas
 
 1 a 10 de 10